samedan logo

home > news > detailed info

Avantor Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain


New facility in Westminster, Mass., provides reliable and comprehensive support for single-use business.

RADNOR, Pa., Dec. 15, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it has opened a new single-use logistics hub in Westminster, Massachusetts, to strengthen the Company's global biopharma supply chain.

Located near the Company's Devens, Massachusetts, manufacturing site, the new facility serves as a center for raw material storage, quality control and distribution, streamlining Avantor's supply chain to support the double-digit growth of single-use solutions.

"Our customers require enabling solutions that support their efforts to bring new therapies to market, and Avantor's single-use business offers design and manufacturing support for their bioproduction processes. With the addition of our state-of-the-art Westminster facility, we now provide our customers with not only an end-to-end offering but the operations to comprehensively support it," said Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor. "The site provides distribution and logistics management and allows us to better leverage our existing sites in North America, increasing the efficiencies we bring to our customers and the reliability for which our business is known."
phone 1 610 573 2600
email One Radnor Corporate Center Building One, Suite 200 100 Matsonford Road Radnor, PA 19087
Print this page
Send to a friend
News and Press Releases

Biognosys Partners With Kymera Therapeutics in Precision Proteomics Biomarkers

March 15, 2022 ZURICH Business Wire. Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, and Kymera Therapeutics, a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD), announced today that they are broadly collaborating across preclinical studies and clinical trials.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

Industry Events

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

20-21 June 2022, Berlin, Germany

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement